Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 125: AML Series, Pt 11 - Treatment of patients unfit for intensive therapy

 
Share
 

Manage episode 456141616 series 3377633
Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy.

Episode contents:

- How do we assess fitness for intensive AML?

- What are options for patients who are unfit for intensive chemotherapy for AML?

- What are important genetic mutations are important to check for?

- What are the key trials that inform our management in this space?

- How do we dose venetoclax?

- How do we sequence the available agents?

****Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

  continue reading

144 episodes

Artwork
iconShare
 
Manage episode 456141616 series 3377633
Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy.

Episode contents:

- How do we assess fitness for intensive AML?

- What are options for patients who are unfit for intensive chemotherapy for AML?

- What are important genetic mutations are important to check for?

- What are the key trials that inform our management in this space?

- How do we dose venetoclax?

- How do we sequence the available agents?

****Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

  continue reading

144 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play